Los Angeles has been a major epicenter of the AIDS epidemic since the first cases of this disease were reported from UCLA in 1981. Over the last 29 years, both UCLA and USC have been major centers for research in HIV/AIDS and were two of the first institutions to become heavily involved in the treatment of patients with AIDS related malignancies. These two institutions have chosen to form a combined AMC core site each with its unique strengths and leadership for the Group and to provide two locations where the diverse HIV population of Los Angeles may access AMC trials. The 2 institutions complement each others in their primary areas expertise and major disease populations and trials enrollment. UCLA has primary interest and expertise in HPV, lymphoma and NADC while USC has chosen to focus more on KS, lymphoma and NADC.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project--Cooperative Agreements (U01)
Project #
5U01CA121947-08
Application #
8737182
Study Section
Special Emphasis Panel (ZCA1-SRLB-D)
Project Start
Project End
Budget Start
2014-09-01
Budget End
2015-08-31
Support Year
8
Fiscal Year
2014
Total Cost
$166,391
Indirect Cost
Name
University of California Los Angeles
Department
Type
DUNS #
092530369
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Simon, Jeremy R; Stier, Elizabeth A (2014) If a man needs a gynecologist, will he be able to find one? Ann Intern Med 160:570-1
Adebamowo, Clement A; Casper, Corey; Bhatia, Kishor et al. (2014) Challenges in the detection, prevention, and treatment of HIV-associated malignancies in low- and middle-income countries in Africa. J Acquir Immune Defic Syndr 67 Suppl 1:S17-26
Beumer, J H; Venkataramanan, R; Rudek, M A (2014) Pharmacotherapy in cancer patients with HIV/AIDS. Clin Pharmacol Ther 95:370-2
Yang, Dongmei; Chen, Wuguo; Xiong, Jie et al. (2014) Interleukin 1 receptor-associated kinase 1 (IRAK1) mutation is a common, essential driver for Kaposi sarcoma herpesvirus lymphoma. Proc Natl Acad Sci U S A 111:E4762-8
Gopal, Satish; Patel, Monita R; Achenbach, Chad J et al. (2014) Lymphoma immune reconstitution inflammatory syndrome in the center for AIDS research network of integrated clinical systems cohort. Clin Infect Dis 59:279-86
Rudek, Michelle A; Moore, Page C; Mitsuyasu, Ronald T et al. (2014) A phase 1/pharmacokinetic study of sunitinib in combination with highly active antiretroviral therapy in human immunodeficiency virus-positive patients with cancer: AIDS Malignancy Consortium trial AMC 061. Cancer 120:1194-202
Bayraktar, Ulas Darda; Diaz, Luis A; Ashlock, Brittany et al. (2014) Zidovudine-based lytic-inducing chemotherapy for Epstein-Barr virus-related lymphomas. Leuk Lymphoma 55:786-94
Hosseinipour, Mina C; Sweet, Kristen M; Xiong, Jie et al. (2014) Viral profiling identifies multiple subtypes of Kaposi's sarcoma. MBio 5:e01633-14
Barta, Stefan K; Xue, Xiaonan; Wang, Dan et al. (2014) A new prognostic score for AIDS-related lymphomas in the rituximab-era. Haematologica 99:1731-7
Deperalta, Danielle K; Hoang, Mai P; Tanabe, Kenneth K (2014) Approaches to regional nodes in patients with melanoma. J Clin Oncol 32:881-5

Showing the most recent 10 out of 73 publications